While the microarray industry is expanding the frontiers of this technology into agriculture, food safety, and even outer space, the platform remains closely linked to the challenges of drug discovery.

And you only have to look at attendance for two third-quarter trade shows — Drug Discovery Technology in Boston starting on Aug. 8, and Chips to Hits on Sept. 20-23, also in Boston — for an illustration (see chart, page 5.)

The two shows are organized by IBC Life Sciences of Westborough, Mass., as part of its drug discovery series.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.